Shenzhen Chipscreen Biosciences Co (688321) — Capital Reinvestment Ratio
Shenzhen Chipscreen Biosciences Co (688321) has a Capital Reinvestment Ratio of 27.48x as of September 2025, meaning it reinvests 27% of its operating cash flow (CN¥2.25 Million) in capital expenditures (CN¥61.73 Million). Check Shenzhen Chipscreen Biosciences Co (688321) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen Chipscreen Biosciences Co Capital Reinvestment Ratio (2016–2024)
This chart tracks Shenzhen Chipscreen Biosciences Co's Capital Reinvestment Ratio across 7 annual periods. For the full cash flow conversion analysis, see Shenzhen Chipscreen Biosciences Co cash conversion from operations.
Annual Capital Reinvestment Ratio for Shenzhen Chipscreen Biosciences Co (2016–2024)
Year-by-year Capital Reinvestment Ratio for Shenzhen Chipscreen Biosciences Co from 2016 to 2024. See 688321 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 3.53x | CN¥76.13 Million | CN¥268.49 Million | ▼ -61.8% |
| 2022 | 9.24x | CN¥43.30 Million | CN¥400.17 Million | ▲ +299.8% |
| 2021 | 2.31x | CN¥124.78 Million | CN¥288.46 Million | ▼ -35.6% |
| 2020 | 3.59x | CN¥93.62 Million | CN¥336.27 Million | ▼ -41.9% |
| 2018 | 6.18x | CN¥22.78 Million | CN¥140.74 Million | ▼ -87.3% |
| 2017 | 48.65x | CN¥2.73 Million | CN¥132.82 Million | ▲ +4318.2% |
| 2016 | 1.10x | CN¥59.77 Million | CN¥65.81 Million | — |